Amr Amin, Alaaeldin A. Hamza, Khuloud Bajbouj, S. Salman Ashraf, Sayel Daoud – 23 May 2011 – Saffron has been proposed as a promising candidate for cancer chemoprevention. The purpose of this investigation was to investigate the chemopreventive action and the possible mechanisms of saffron against diethylnitrosamine (DEN)‐induced liver cancer in rats. Administration of saffron at doses of 75, 150, and 300 mg/kg/day was started 2 weeks prior to the DEN injection and was continued for 22 weeks.

Diego F. Calvisi – 23 May 2011

Nicola Coppola, Mariantonietta Pisaturo, Salvatore Guastafierro, Gilda Tonziello, Antonello Sica, Caterina Sagnelli, Maria Giovanna Ferrara, Evangelista Sagnelli – 23 May 2011

Luca Mascitelli, Mark R. Goldstein – 23 May 2011

Liang Peng, Dong‐ying Xie, Bing‐Liang Lin, Jing Liu, Hai‐peng Zhu, Chan Xie, Yu‐bao Zheng, Zhi‐liang Gao – 23 May 2011 – Our study aimed to investigate the short‐term efficacy and long‐term prognosis of liver failure patients caused by hepatitis B after a single transplantation with autologous marrow mesenchymal stem cells (MMSCs). A total of 527 inpatients with liver failure caused by hepatitis B were recruited and received the same medical treatments, among whom 53 patients underwent a single transplantation with autologous MMSCs.

Georgios N. Kalambokis, Epameinondas V. Tsianos – 23 May 2011

Staffan Wahlin, Per Stal, Rene Adam, Vincent Karam, Robert Porte, Daniel Seehofer, Bridget K. Gunson, Jens Hillingsø, Jürgen L. Klempnauer, Jan Schmidt, Graeme Alexander, John O'Grady, Pierre‐Alain Clavien, Mauro Salizzoni, Andreas Paul, Keith Rolles, Bo‐Göran Ericzon, Pauline Harper, for the European Liver and Intestine Transplant Association – 20 May 2011 – Liver transplantation is an established lifesaving treatment for patients with severe protoporphyric liver disease, but disease recurrence in the graft occurs for the majority of recipients.

Mary Ann Simpson, Julia Kendrick, Jennifer E. Verbesey, Denise S. Morin, Mary Amanda Dew, Agnes Trabucco, James J. Pomposelli, Elizabeth A. Pomfret – 20 May 2011 – All right hepatic lobe (RHL) donors in our program are asked to participate in a longitudinal quality‐of‐life study that begins at their evaluation and continues throughout the first postdonation year. Here we report the characteristics of donor candidates who completed the donation process despite ambivalence. In all, 183 RHL candidates consented, and 133 became donors.

Deepak K. Ozhathil, You Fu Li, Jillian K. Smith, Jennifer F. Tseng, Reza F. Saidi, Adel Bozorgzadeh, Shimul A. Shah – 20 May 2011 – The use of high‐risk donor livers, which is reflective of the gross national shortage of organs available for transplantation, has gained momentum. Despite the demand, many marginal livers are discarded annually. We evaluated the impact of center volume on survival outcomes associated with liver transplantation using high–donor risk index (DRI) allografts.

Samanta T. Basto, Cristiane A. Villela‐Nogueira, Bernardo R. Tura, Henrique Sergio M. Coelho, Joaquim Ribeiro, Eduardo S. M. Fernandes, Alice F. Schmal, Livia Victor, Ronir R. Luiz, Renata M. Perez – 20 May 2011 – Liver donor shortage and long waiting times are observed in many liver transplant programs worldwide. The aim of this study was to evaluate the wait list in a developing country, before and after the introduction of the MELD scoring system. In addition, the MELD score ability to predict mortality in this setting was assessed.